James B. Breitmeyer, CEO: Oncternal Therapeutics ONCT Buy · Filed 23/04/17

Trade details

Type: Insider buy
Amount: $14,325
Shares · price: 47,750 sh · $0.30 a share
Held after: 194,294 sh
Stock: Oncternal Therapeutics ONCT
Person: James B. BreitmeyerCEO
Trade date: 23/04/14
Filed: 23/04/17
Days to filing: 3 days

4 insiders bought this week

Insiders buying this week: 4 insiders
Holding change: +32.6%

Oncternal Therapeutics trades, last 26 weeks

What else happened in Oncternal Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/15~23/05/14

James B. Breitmeyer's recent trades

James B. BreitmeyerCEO
BuyOncternal Therapeutics
Buy
Oncternal Therapeutics
ONCT
$29K
100,000 sh
$29K
Filed 23/04/17
Traded 23/04/13
James B. BreitmeyerCEO
BuyOncternal Therapeutics
Buy
Oncternal Therapeutics
ONCT
$653
2,250 sh
$653
Filed 23/04/17
Traded 23/04/14

James B. Breitmeyer, CEO — bought $14.3K of Oncternal Therapeutics ONCT · 47,750 sh @ $0.30 | Whalegun